MicroRNAs (miRNAs) are endogenous noncoding RNAs (~22 nt) that regulate target gene expression at the posttranscriptional level in the cytoplasm. Recent discoveries of the presence of miRNAs and miRNA function-required argonaute family proteins in the cell nucleus have prompted us to hypothesize that miRNAs may also have regulatory functions in the cell nucleus. In this study, we demonstrate that mouse miR-709 is predominantly located in the nucleus of various cell types and that its nuclear localization pattern rapidly changes upon apoptotic stimuli. In the cell nucleus, miR-709 directly binds to a 19-nt miR-709 recognition element on pri-miR-15a/16-1 and prevents its processing into pre-miR-15a/16-1, leading to a suppression of miR-15a/16-1 maturation. Furthermore, nuclear miR-709 participates in the regulation of cell apoptosis through the miR-15a/16-1 pathway. In summary, the present study provides the first evidence that one miRNA can control the biogenesis of other miRNAs by directly targeting their primary transcripts in the nucleus.
Introduction
MicroRNAs (miRNAs) are noncoding endogenous RNA molecules (18-25 nt) that have emerged as a new class of gene regulators at the post-transcriptional level [1, 2] . Previous studies [1, 3] have established a model for the biogenesis and function of miRNAs. The miRNA gene is first transcribed by RNA polymerase II or RNA polymerase III into primary miRNA transcript (pri-miR-NA), and the pri-miRNA is then cleaved into precursor miRNA (pre-miRNA; 60-80 nt) by the nuclear microprocessor complex formed by Drosha and DGCR8. PremiRNA is then transported by Exportin-5 in a RanGTPdependent manner into the cytoplasm where it is further cleaved into a double-stranded miRNA/miRNA* duplex by Dicer. Finally, one strand of the duplex (mature miRNA) is incorporated into the RNA-induced silencing complex (RISC), which further guides its function via translational repression or mRNA cleavage [4] [5] [6] . According to this model, mature miRNAs execute their functions mainly in the cytoplasm. However, recent studies have revealed that there is an extensive amount of mature miRNAs and core proteins of the RISC, such as argonaute (AGO) family proteins (AGO1 and AGO2), in the nucleus [7] [8] [9] [10] [11] . Based on these findings, we propose that mature miRNAs in the nucleus may directly target other nuclear noncoding RNAs, particularly pri-miRNA transcripts, thereby, modulating the biogenesis and function of these miRNAs. In the present study, we demonstrate that mouse miR-709 is located predominantly in
Results

Predominant localization of miR-709 in the nucleus
To obtain the nuclear miRNA profile, we purified the nuclei from HEK-293T cells or C57BL/6J mouse livers using a well-defined procedure [9] , and the high purity of the isolated nuclear fractions was validated using critical nuclear RNA and protein markers including U6 small nuclear RNA and H2A histone protein (Supplementary information, Figure S1A and S1B). Hoechst 33258 staining also showed that purified nuclei were mostly intact with clear membrane boundaries (Supplementary information, Figure S1C ). A survey of miRNA expression in mouse liver nuclei on a genome-wide scale was performed using a miRNA microarray assay. As compared to cellular miRNAs [12] , nuclear miRNAs had a different expression pattern. A total of 1 163 mammalian miRNAs were analyzed, and a panel of miRNAs including miR-709, miR-805, miR-690 and miR-122 was found to be enriched in the nucleus ( Figure 1A ). A total of 44 miRNAs with the highest nuclear expression levels were further examined by a TaqMan probe-based quantitative real-time polymerase chain reaction (qRT-PCR) assay (Supplementary information, Table S1 ), and the results confirmed that miR-709, miR-690 and miR-30e were highly expressed in the nucleus ( Figure 1B ).
Because the predominant nuclear expression of miR-709 was confirmed by both microarray and qRT-PCR assays, we selected miR-709 as the nuclear-enriched miRNA for further analysis. First, we examined the nuclear expression profile of miR-709 in different tissues in C57BL/6J mice, and the results clearly showed miR-709 as a ubiquitous nuclear miRNA (Supplementary information, Figure S2 ). Second, we quantitatively evaluated the nuclear enrichment of miR-709 in mouse L929 cells using miR-29a, a typical cytoplasmic miRNA [9] , as a negative control. As shown in Figure 1C , miR-709 was predominantly located in the nucleus with a relative abundance that is > 95%, whereas miR-29a was not or only weakly detected in the nucleus (< 0.5%). A localization study in mouse L929 cells using synthetic miR-709 and miR-29a mimics further confirmed the nuclear localization of transfected miRNA mimics of miR-709 and the cytoplasmic localization of miR-29a ( Figure 1D ). In addition, synthetic pre-miR-709 and anti-miR-709 antisense oligonucleotides (ASOs) effectively impacted the nuclear miR-709 levels in mouse L929 cells and human HEK-293T cells (Supplementary information, Figure  S3 ).
miR-709 negatively regulates miR-15a and miR-16-1 in mice
To test the hypothesis that nuclear miR-709 may directly affect the biogenesis of other miRNAs, we applied miRNA microarray assays to analyze the expression differences of miRNAs in cells with overexpressed or depleted miR-709. Among the 600 mouse miRNAs analyzed, miR-16-1 had the most significant upregulation in cells when miR-709 was depleted (Figure 2A) . In agreement with these results, miR-16-1 was downregulated with the overexpression of miR-709 (Supplementary information, Figure S4 ).
Computational analysis further suggested that a putative 19-nt binding site for miR-709 exists on mouse primiR-15a/16-1 and that it is ~0.8 kb downstream of the miR-15a/16-1 gene loci ( Figure 2B ). The minimum free energy (∆G) predicted for hybridization of miR-709 with pri-miR-15a/16-1 at this site is −41.5 kcal/mol as determined by RNA hybrid analysis [13] . Interestingly, in addition to miR-15a/16-1, the miR-16 gene has an additional copy in the mouse genome, which is called miR15b/16-2, but the expression levels of these genes are significantly lower than miR-15a [14] and do not significantly contribute to the overall population of miR-16 [15] . We searched for putative miR-709-binding sites on primiR-15b/16-2, but we did not find any hits according to our target prediction algorithm. In agreement with miR-709 being a mouse-specific miRNA, the putative binding site of miR-709 was not found on human pri-miR15a/16-1. These findings suggest that miR-709 may affect miR-15a/16-1 in mice but that it may not affect miR15b/miR-16-2 in mice or miR-15a/miR-16-1 in humans.
An inverse correlation between the nuclear miR-709 level and pri-miR-15a/16-1 processing efficiency was detected among different mouse tissues. The transcriptional activity of the miR-15a/16-1 cluster in different mouse tissues was indicated by the relative expression level of pri-miR-15a/16-1. Figure 2C shows that although the transcriptional activity of pri-miR-15a/16-1 varied among different tissues, the expression level of mature miR-16 remained generally the same. The Pearson's correlation coefficient between the transcriptional activity of pri-miR-15a/16-1 and level of mature miR-16 was close to 0 (R = −0.077), further suggesting a strong post-transcriptional regulation during miR-16 maturation ( Figure  2C ). When we normalized mature miR-16 levels in dif- ferent tissues to the transcriptional activity of its gene (termed processing efficiency in Figure 2D ), a modest inverse correlation existed between the nuclear miR-709 level and pri-miR-15a/16-1 processing efficiency with an R value of −0.46. If the liver was excluded, which has an extremely high nuclear miR-709 level, the Pearson's cor- Figure S5 ). These analyses strongly suggest a negative regulatory role for nuclear miR-709 in pri-miR-15a/16-1 processing.
To examine if miR-709 in the nucleus regulates the levels of mature miR-15a and miR-16-1, L929 cells were transfected with pre-miR-709 or anti-miR-709 ASOs. Mature miR-15a and miR-16-1 levels were examined by qRT-PCR. Serving as a control, the expression level of miR-15b, which has no putative binding site for miR-709 in the primary transcript, was also examined. As shown in Figure 2E and 2F, levels of mature miR-15a and miR-16-1 were decreased by nuclear miR-709 24 h posttransfection, and no effect of miR-709 on the miR-15b level was observed at this time.
Because human pri-miR-15a/16-1 do not have the putative 19-nt binding site for miR-709, we predicted that miR-709-mediated regulation of human miR-15a/16-1 would not be detected. To test this hypothesis, we employed the human-derived cell line, HEK-293T, and two additional mouse cell lines, NIH-3T3 and 3T3-L1, for the experiment. The cellular levels of miR-16-1 were detected after overexpression or depletion of miR-709. In support of our prediction, the results showed that mature miR-16-1 levels were decreased by nuclear miR-709 in the two mouse cell lines and that no significant changes were detected in the human HEK-293T cells ( Figure 2G and 2H).
miR-709 prevents the processing of pri-miR-15a/16-1 into pre-miRNA in the nucleus via direct binding to primiR-15a/16-1
We next tried to identify the mechanism underlying the negative regulatory effect of nuclear miR-709 on the biogenesis of miR-15a/16-1. First, we found that miR-709 had no impact on the transcriptional activity of the miR-15a/16-1 cluster. By comparing the kinetics of primiR-15a/16-1 and miR-16 levels during miR-709-mediated regulation, we found that mature miR-16-1 gradually decreased or increased following the overexpression Figure 3A ). To confirm this phenomenon, we labeled neo-synthesized pri-miR-15a/16-1 by co-transfection with biotin-16-UTP (50 μmol/ml; Roche). Biotinylated RNA was purified via streptavidin-coated magnetic beads. At 2 h post-treatment, there were no significant differences in the levels of neo-synthesized biotin-labeled pri-miR-15a/16-1 in cells with miR-709 overexpression, miR-709 depletion or scrambled siRNA duplex overexpression ( Figure 3B ). Second, we applied a synthetic pre-miR-16 mimic by cotransfection with miR-709 to assess the effect of miR-709 on pre-miRNA processing. As shown in Figure 3C , miR-709 had no effect on pre-miR-16 processing. It is possible that the impact of miR-709 on mouse miR-15a/miR-16-1 may be due to general competition for the miRNA processing apparatus in the cytoplasm. To exclude this possibility, we transfected mouse L929 cells with a miR-16 precursor or antisense oligonucleotides and then examined cellular miR-709 levels. As shown in Figure 3D , there was no significant alteration of miR-709 levels among cells transfected with a miR-16-1 precursor, miR-16-1 antisense oligonucleotide or scrambled siRNA duplex controls. The results suggest that the regulation of mouse miR-15a/16-1 by miR-709 is unidirectional and that the general competition for the miRNA processing apparatus in the cytoplasm does not have a major role in miR-709-mediated miRNA regulation. Given that nuclear miR-709 did not affect either the transcriptional activity of miR-15a/16-1 ( Figure 3A and 3B) or the processing of pre-miR-16 ( Figure 3C and 3D), we hypothesized that nuclear miR-709 negatively regulated miR-15a/16-1 maturation at the post-transcriptional level and, more specifically, at a stage after pri-miRNA transcription but before pre-miRNA cleavage.
Moreover, because miR-15a/16-1 resides in the Dleu2 intron ( Figure 4A ), we also determined the effect of nuclear miR-709 on Dleu2 mRNA and found that nuclear miR-709 also had a negative effect on Dleu2 mRNA processing ( Figure 4B ).
To further test if the 19-nt miR-709 recognition element on mouse pri-miR-15a/16-1 was responsible for miR-709 binding and blockade of miR-15a/16-1 biogenesis, we modified the human miR-16 expression vector by inserting the 19-nt miR-709 recognition element into the miR-16-1 expression vector ( Figure 5A ) and then overexpressed the modified vector in human HEK-293T cells. As shown in Figure 5B , co-transfection of premiR-709 and the modified human miR-16 expression vector (pcDNA-miR-16-INS) into human HEK-293T A luciferase reporter assay was also employed to demonstrate the direct binding of miR-709 to pri-miR15a/16-1. In this experiment, the WT or mutant (MUT) miR-709 complementary site (CS) was cloned into a luciferase reporter plasmid ( Figure 5C ), and the plasmids were separately co-transfected with pre-miR-709 into HEK-293T cells. As expected, the WT luciferase reporter activity was significantly reduced following pre-miR-709 transfection, whereas the MUT luciferase reporter activity was unaffected ( Figure 5D ), suggesting that the 19-nt miR-709 recognition element is necessary for miR-709-mediated regulation of miR-15a/16-1 biogenesis. We further applied a biotin-avidin pull-down system to assess the direct binding of miR-709 to pri-miR15a/16-1. Briefly, a biotin-labeled-specific anti-primiR-15a/16-1 probe was designed and incubated with nuclear lysate from L929 cells. Pri-miR-15a/16-1 was co-precipitated via avidin-conjugated magnetic beads, and the level of miR-709 in the pull-down complex was analyzed by qRT-PCR ( Figure 5E ). As shown in Figure  5F , miR-709 was significantly enriched (~10-fold higher) in the pri-miR-15a/16-1 pull-down product as compared to the mutated pri-miR-15a/16-1 probe, random probe or no probe pull-down products, indicating that miR-709 can directly bind to pri-miR-15a/16-1 in the nucleus. Interestingly, pri-miR-15a/16-1 showed almost equal enrichment as miR-709 in the pull-down products, which may implicate a one-to-one recognition ratio between these two miRNAs. Taken together, these data suggest that nuclear miR-709 can prevent the processing of primiR-15a/16-1 to pre-miRNA by directly binding to the 19-nt recognition element on pri-miR-15a/16-1. 
miR-709 participates in the regulation of cell apoptosis via the miR-15a/16-1 pathway
Because miR-15a/16-1 is a well-known miRNA cluster that induces cell apoptosis by targeting the antiapoptotic gene, Bcl-2 [16] , we tested if alteration of miR15a/16-1 by nuclear miR-709 had a biological role in cell apoptosis. In this experiment, we examined the expression pattern of miR-15a/16-1 during apoptosis under serum starvation conditions [17] . As expected, after a 12-h serum starvation, cellular levels of miR-16-1 and miR15a in L929 cells were significantly upregulated (Supplementary information, Figure S6C ), which correlated with a significant amount of cell apoptosis as detected by PI/Annexin V double staining [18] (Supplementary information, Figure S6A and S6B). Interestingly, a rapid downregulation of miR-709 in the nucleus was detected at an early stage following serum depletion. As shown in Figure 6A , nuclear miR-709 rapidly decreased to 50% and 5% of the original level after serum depletion for 1 and 3 h, respectively. Surprisingly, the total cellular level of miR-709 remained largely unchanged within the same time frame. These results suggested a redistribution of miR-709, which may have been due to a rapid export of miR-709 from the nucleus to the cytoplasm under apoptotic stress. Although the mechanism for the export of mature nuclear miR-709 remains unknown, the downregulation of miR-709 in the nucleus leads to a loss of the inhibition of pri-miR-15a/16-1 processing by miR-709, which may contribute to the rapid elevation of cellular miR-15a/16-1 levels during apoptosis.
The role of nuclear miR-709 in the regulation of serum starvation-induced L929 cell apoptosis was further analyzed. As shown in Figure 6B , overexpression of miR-709 was sufficient to induce the upregulation of Bcl-2 in L929 cells. Importantly, co-expression of miR-16 and miR-709 in L929 cells effectively abolished miR-709-induced Bcl-2 upregulation, suggesting that Bcl-2 upregulation induced by miR-709 occurred through the downregulation of cellular miR-16. The same conclusion was drawn from the experiment in which depletion of miR-709 resulted in an elevation of miR-16 and downregulation of Bcl-2.
Downregulation of miR-709 in the nucleus and associated elevation of cellular miR-15a/16-1 were also observed during TNF-α-induced cell apoptosis. As shown in Figure 6D , TNF-α treatment for 12 and 24 h resulted in a significant decrease in nuclear miR-709 levels but an increase in cytoplasmic miR-709 levels. However, the total cellular miR-709 level was not changed during treatment. As expected, TNF-α treatment caused cell apoptosis (Supplementary information, Figure S7 ). In cells treated with TNF-α for 24 h, similar results were obtained where the overexpression of miR-709, through the downregulation of cellular miR-16, induced the upregulation of Bcl-2 ( Figure 6E ) and reduced cell apoptosis (Supplementary information, Figure S7 ). Together, these results confirmed the anti-apoptotic role of nuclear miR-709 through the miR-16/Bcl-2 pathway. As shown in Figure 6F , miR-709 protected cells from apoptosis, and the protective effect of miR-709 was abolished by increased levels of miR-16-1. Interestingly, nuclear miR-709 impacted Bcl-2 expression and the cell apoptotic ratio almost to the same extent as miR-16-1, which generally executed its function in the cytoplasm.
Discussion
This study presents compelling evidence that mouse miR-709 can regulate miR-15a/16-1 biogenesis at the post-transcriptional level by directly binding to a 19-nt recognition element on pri-miR-15a/16-1 in the nucleus. Moreover, this study demonstrates that miR-709 can participate in the regulation of cell apoptosis through modulating miR-16 maturation. This finding significantly expands the biological function of miR-709. Although miR-709 is highly expressed in various tissues and cell types during different developmental stages in mice including embryo, testes, liver, brain, ovaries, spinal cord, heart, bladder smooth muscles, cardiomyocytes and oligodendrocytes, only one validated mRNA target has been reported for this ubiquitously expressed miRNA, in which it partakes in the regulation of DNA methylation in the male germline via targeting BORIS [19] . However, based on our model illustrated in Figure 6E , miR-709, which is predominantly expressed in the nucleus, can execute its biological function by "supervising" the biogenesis of miR-15a/miR-16-1. This supervision, in turn, constitutes a short-term regulatory cascade with a quick response to apoptotic stress independent of any neo transcription. To the best of our knowledge, this is the first report on the direct miRNA-mediated regulation of biogenesis and function of miRNAs although previous studies have shown inter-miRNA antagonisms [20, 21] and protein-mediated post-transcriptional control in miR-NA biogenesis [22] [23] [24] . Interestingly, Tamminga et al. [19] showed that the in situ hybridization signal of miR-709 is predominately located in the nucleus. Maes et al. [25] also reported that miR-709 and other proliferation essential miRNAs, such as miR-214, are significantly increased during the aging process in the liver. Both of these studies indirectly support the model in the present study. One may argue that miR-709 may directly regulate Bcl-2 through classic miRNA/mRNA interactions instead of modulating miR-16 biogenesis. However, this
npg possibility is low based on the following results: (a) miR-709 elevated the level of Bcl-2 expression rather than suppressing the level of Bcl-2 expression ( Figure 6 ); and (b) miR-709 functioned only in the nucleus and was not available for any predicted cytoplasmic mRNA targets ( Figure 1 ). The mechanism underlying the predominant localization of miR-709 in the nucleus remains unknown at this stage and requires further study. A previous study has reported that hexanucleotide elements may contribute to the nuclear transport of certain miRNAs, such as miR29b [9] . However, miR-709 does not have a hexanucleotide element. According to the results of the present study ( Figure 1D and Supplementary information, Figure  S3) showing that the identical nucleotide sequence in the miR-709 mimic was sufficient for its nucleus/cytoplasm shuttling and that changing cytoplasmic miR-709 populations impacted nuclear miR-709 populations, we suggest that there is an equilibrium between nuclear and cytoplasmic miR-709 and that the predominate nuclear localization pattern is determined by its inborn primary sequence identity. Furthermore, although miR-709 is a mouse-specific miRNA, the microarray and computational analyses performed in this study implicate that such direct miRNA/miRNA interactions may be a general phenomenon. Various miRNA targets of miR-709 other than miR-15a/16-1 were predicted in mouse revealing two highly conserved recognition patterns, which we named as "No. 6 bubble" and "No. 16 bubble", respectively (Supplementary information, Figure S8A , S8B, and Table S2) .
It is generally believed that biological processes are controlled by activating a hierarchical cascade of interdependent regulators, such as transcription factors or protein kinases [26, 27] . By illustrating that a miRNA can regulate the biogenesis of other miRNAs, the results of the present study suggest that certain miRNAs can serve as a novel group of interdependent regulators at post-transcriptional level, in a so-called "miRNA hierarchy system" (Supplementary information, Figure S9 ). In summary, the present study demonstrates for the first time that mouse miR-709 can directly target the primary transcript of miR-15a/16-1 in the nucleus and control their biogenesis. The discovery of miRNA-mediated regulation of miRNA biogenesis provides the first evidence of a potential hierarchical structure among miRNAs.
Materials and Methods
Reagents, cells and antibodies
The mouse L929, NIH-3T3, 3T3-L1 and human HEK-293T cell lines were purchased from the China Cell Culture Center (Shanghai, China). Cells were maintained at 37 °C in a humidified 5% CO 2 incubator in Dulbecco's Modified Eagle's Medium (GIBCO, CA, USA) containing 10% fetal bovine serum (Gibco, CA, USA), 100 units/ml penicillin and 100 µg/ml streptomycin. An anti-Bcl-2 (50E3) antibody was purchased from Cell Signaling (Danvers, MA, USA), and anti-GAPDH and anti-Histone H2A (C-19) antibodies were purchased from Santa Cruz Biotechnology (CA, USA). Synthetic RNA molecules including pre-miR-709, anti-miR-709, pre-miR-16, anti-miR-16 and scrambled negative control oligonucleotides (pre-ncRNA and anti-ncRNA) were purchased from Ambion (Austin, TX, USA). Synthetic 5′-FAMlabeled miR-709 and miR-29a oligonucleotide duplexes were purchased from Invitrogen (Shanghai, China).
Preparation of subcellular organelles
For the purification of nuclei, cells (tissues were processed and filtered through a cell strainer to obtain cell suspensions) were washed three times with PBS on ice followed by centrifugation at 300× g for 5 min. Cell pellets were resuspended in lysis buffer (10 mM Tris, pH 8.0; 140 mM NaCl, 1.5 mM MgCl 2 , and 0.5% nonidet P-40), incubated on ice for 10 min, and then centrifuged at 1 000× g for 5 min at 4 °C. Nuclear pellets were washed twice with lysis buffer followed by a final wash with nuclear wash buffer (lysis buffer containing 1% Tween-40 and 0.5% deoxycholic acid). For liver mitochondria purification, adult male C57BL/6 mice (6-8 weeks) were fasted for 12 h and sacrificed by exsanguination under ether anesthesia followed by cervical dislocation. The livers were removed and rinsed in physiological saline. Approximately 3 g of minced liver was prepared as a 10% (wt/vol) homogenate in an ice-cold solution of homogenate buffer containing 250 mM sucrose and 10 mM Tris-HCl (pH 7.4). The homogenate was centrifuged at 700× g for 10 min at 4 °C with 340 mM sucrose and 10 mM Tris-HCl (pH 7.4). The supernatant was centrifuged for 10 min at 10 000× g, and the mitochondrial pellet was then washed twice under the same conditions using EGTA-and EDTA-depleted wash buffer.
Transfection of cells with ncRNA, pre-miRNA or anti-miRNA
Cells were seeded in 6-well plates or 10-mm dishes, and they were transfected the following day using Lipofectamine 2000 (Invitrogen) according to the manufacturer's instructions. For the transfection, 20 pmol RNA or 5 pmol plasmid DNA per 10 5 cells was used. Cells were harvested 24 h after transfection for real-time PCR analysis and western blotting.
microRNA microarray
Total RNA (50 µg) was purified using the mirVANA miRNA isolation kit (Ambion, Inc.) to enrich the small RNA fraction. Purified RNA was labeled with fluorescein, and hybridization was performed on a miRNA microarray chip (miRNA microarray V4.0, CapitalBio Corp., Beijing, China) containing 1 320 probes in triplicate corresponding to 988 human, 627 mouse and 350 miRNA genes. Finally, hybridization signals were detected, and scanner images were quantified.
RNA isolation and qRT-PCR of mature miRNAs
Total RNA was extracted from cells or tissues using Trizol reagent (Invitrogen). qRT-PCR was carried out using TaqMan miR-NA probes (Applied Biosystems, Foster City, CA, USA) according to the manufacturer's instructions. Briefly, total RNA was reverse transcribed to cDNA using M-MLV reverse transcriptase (Promega) and a stem-loop RT primer (Applied Biosystems). Real-time PCR was performed using a TaqMan PCR kit and an Applied Biosystems 7900 Sequence Detection System (Applied Biosystems). All reactions including no template controls were run in triplicate. After the reaction, the C T values were determined using fixed threshold settings. miRNA expression in the cells or nuclei was normalized to U6 snRNA, and mRNA expression in the cells was normalized to β-actin. The following primer sequences were used: pri-15a/16-1 forward,TCTGTAAATTACTATTGAGGTGCTAGG AGT; pri-15a/16-1 reverse,TACAGTTGTAGAGTATTGCCAAC CTTACTT; U6 forward, CTCGCTTCGGCAGCACA; U6 reverse, AACGCTTCACGAATTTGCGT; Dleu2 forward, GCAGACCG-GCCTAGGGGACA; Dleu2 reverse, AGCGACGGAGGAAGAC-CCCC; β-actin forward, GAGACCTTCAACACCCCAGC; and β-actin reverse, ATGTCACGC ACGATTTCCC.
Pri-miR-15a/16-1 pull-down assay
Briefly, a DNA probe complementary to mouse pri-miR15a/16-1 was synthesized, labeled with biotin at both 5′ and 3′ terminals and dissolved in 500 µl of wash/binding buffer (0.5 M NaCl; 20 mM Tris-HCl, pH 7.5; and 1 mM EDTA) at a final concentration of 8 pmol/µl. The probe was then incubated with streptavidin-coated magnetic beads (New England BioLabs, Cat. S1420S) at 25 °C for 1 h to generate probe-coated magnetic beads. Purified nuclear lysate was pretreated with DNase I (Takara, Cat. D2210) and then incubated with probe-coated beads at 37 °C for 3 h. After washing four times with the wash/binding buffer, a magnet was applied to cause the beads/RNA complex to bind to the side of the tube. RNA was eluted from the streptavidin beads with 10 mM EDTA (pH 8.2) by incubation at 90 °C for 10 min, and the RNA was analyzed by qRT-PCR. The following primer sequences were used: anti-pri-miR-15a/16-1 pull-down probe, TCATGGCAGC-CTGGTCTACATGG; and random pull-down probe, TGAT-GTCTAGCGCTT GGGCTTTG.
Western blot analysis
Samples of tissues and cultured cells were lysed in a buffer (50 mM Tris-HCl, pH 7.4; 150 mM NaCl; 1% NP-40; and 0.1% SDS), sonicated (6 × 1.5 sec, 30% power) and centrifuged at 12 000 × g for 10 min at 4 °C. The supernatant fraction was removed, and the protein concentration was determined by a BCA assay (Pierce, Rockford, USA). Aliquots of proteins (60-100 µg) were separated on 10% sodium dodecyl sulfate-polyacrylamide gels (SDS-PAGE) and transferred to polyvinylidene difluoride membranes. The membranes were blocked for 1 h at room temperature with 5% non-fat milk in Tris-buffered saline (TBS) plus Tween-20 (TBST) followed by an overnight incubation at 4 °C with antibodies diluted in blocking buffer. After three 10-min washes with TBST, blots were incubated at room temperature for 1 h with the appropriate secondary antibody conjugated to horseradish peroxidase, and protein expression was detected with an enhanced chemiluminescent reagent (Cell Signaling). The autoradiographic intensity of each band was scanned and quantified using BandScan software (Glyko Inc.).
Plasmid construction
To construct pcDNA-miR-16-WT, a 93-bp sequence of premiR-16-1 was amplified by PCR using mouse genomic DNA as a template. The PCR product was inserted into the pcDNA6.2-GW/ EmGFP-miR plasmid (Invitrogen). To construct pMIR-luc-pri-WT, a 1.6-kb sequence downstream of mouse pri-miR-15a/16-1 was amplified by PCR using mouse genomic DNA as a template. The PCR product was inserted into the pMIR-report plasmid (Ambion). Efficient insertion was confirmed by sequencing.
Luciferase reporter assay
For luciferase reporter assays, 0.2 µg of firefly luciferase reporter plasmid, 0.1 µg of β-galactosidase expression vector (Ambion) and equal amounts (20 pmol) of pre-miR-709 or scrambled negative control RNA were transfected into cells plated in 24-well plates. The β-galactosidase vector was used as a transfection control. At 24 h post-transfection, cells were assayed using luciferase assay kits (Promega).
Statistical analysis
Real-time PCR was performed in triplicate, and each experiment was repeated at least three times. Data were presented as the means ± SD of at least three independent experiments, and differences were considered statistically significant at P < 0.05 using Student's t-test.
